Active, not recruitingNCT07494058

A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in Mexico

Studying Lysosomal disease

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Takeda
Principal Investigator: Study Director
Takeda
Intervention: No intervention(other)
Enrollment: 222 enrolled
Eligibility: All sexes
Timeline: 2025 – 2026

Study locations (1)

Takeda Site, Mexico City, Mexico

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07494058 on ClinicalTrials.gov

Other trials for Lysosomal disease

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1, PHASE2NCT04464759
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Ravi Amaravadi, MD

See all trials for Lysosomal disease →

← Back to all trials